The role of the Birt–Hogg–Dubé protein in mTOR activation and renal tumorigenesis
Open Access
- 23 February 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 28 (13), 1594-1604
- https://doi.org/10.1038/onc.2009.14
Abstract
Birt–Hogg–Dubé (BHD) syndrome is a tumor-suppressor gene disorder characterized by skin tumors, cystic lung disease and renal cell carcinoma. Very little is known about the molecular pathogenesis of BHD. Clinical similarities between BHD and tuberous sclerosis complex (TSC) suggest that the BHD and TSC proteins may function within a common pathway. The TSC proteins inhibit the activity of the mammalian target of rapamycin complex 1 (TORC1), and in Schizosaccharomyces pombe, Bhd and Tsc1/Tsc2 have opposing roles in the regulation of amino-acid homeostasis. We report here that in mammalian cells, downregulation of BHD reduces the phosphorylation of ribosomal protein S6, an indicator of TORC1 activity. To determine whether folliculin, the product of the BHD gene, regulates mammalian target of rapamycin activity in vivo, we generated a mouse with targeted inactivation of the Bhd gene. The mice developed spontaneous oncocytic cysts and tumors composed of cells that resemble the renal cell carcinomas in BHD patients. The cysts and tumors had low levels of phospho-S6. Taken together, these data indicate that folliculin regulates the activity of TORC1, and suggest a new paradigm in which both inappropriately high and inappropriately low levels of TORC1 activity can be associated with renal tumorigenesis.This publication has 60 references indexed in Scilit:
- Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal NeoplasiaPLOS ONE, 2008
- Identification and characterization of a novel folliculin-interacting protein FNIP2Gene, 2008
- The UOK 257 cell line: a novel model for studies of the human Birt–Hogg–Dubé gene pathwayCancer Genetics and Cytogenetics, 2008
- Kidney-Targeted Birt-Hogg-Dube Gene Inactivation in a Mouse Model: Erk1/2 and Akt-mTOR Activation, Cell Hyperproliferation, and Polycystic KidneysJNCI Journal of the National Cancer Institute, 2008
- Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signalingProceedings of the National Academy of Sciences of the United States of America, 2006
- Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioningThe Journal of cell biology, 2006
- Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of TuberinPublished by Elsevier BV ,2003
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature, 2003
- Rheb is an essential regulator of S6K in controlling cell growth in DrosophilaNature, 2003
- Prevalence of tuberous sclerosis estimated by capture-recapture analysisThe Lancet, 1998